IMMP2L
Basic information
Region (hg38): 7:110662644-111562517
Previous symbols: [ "IMMP2L-IT1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IMMP2L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 11 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 31 | 36 | ||||
Total | 0 | 0 | 42 | 2 | 7 |
Variants in IMMP2L
This is a list of pathogenic ClinVar variants found in the IMMP2L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-110663631-G-T | not specified | Uncertain significance (Aug 21, 2024) | ||
7-110663646-C-G | not specified | Uncertain significance (Mar 24, 2023) | ||
7-110663649-A-C | not specified | Uncertain significance (Nov 25, 2024) | ||
7-110663677-C-A | not specified | Uncertain significance (Jan 08, 2024) | ||
7-110886634-C-A | not specified | Uncertain significance (Dec 07, 2021) | ||
7-110886648-A-G | not specified | Uncertain significance (Feb 06, 2023) | ||
7-110886657-C-T | not specified | Uncertain significance (Aug 26, 2022) | ||
7-110886658-G-A | Likely benign (Jul 31, 2018) | |||
7-110886666-T-C | IMMP2L-related disorder | Benign (Jun 27, 2019) | ||
7-110886673-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
7-110886679-T-C | not specified | Uncertain significance (Oct 27, 2021) | ||
7-110886690-A-G | not specified | Uncertain significance (Apr 01, 2024) | ||
7-110963057-T-G | IMMP2L-related disorder | Likely benign (Apr 30, 2019) | ||
7-110963510-C-T | not specified | Uncertain significance (May 21, 2024) | ||
7-111122779-G-T | not specified | Uncertain significance (Sep 27, 2021) | ||
7-111122785-C-A | not specified | Uncertain significance (Oct 03, 2022) | ||
7-111122863-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
7-111122864-G-A | Benign (Feb 07, 2018) | |||
7-111122873-C-A | not specified | Uncertain significance (Sep 03, 2024) | ||
7-111123037-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
7-111123100-A-G | not specified | Uncertain significance (Sep 07, 2022) | ||
7-111123248-C-G | not specified | Uncertain significance (Feb 27, 2023) | ||
7-111123263-A-G | not specified | Uncertain significance (Nov 08, 2024) | ||
7-111123447-A-G | Benign (Oct 09, 2017) | |||
7-111123463-G-A | not specified | Uncertain significance (Nov 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IMMP2L | protein_coding | protein_coding | ENST00000405709 | 5 | 899464 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0112 | 0.851 | 125733 | 0 | 12 | 125745 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.173 | 96 | 101 | 0.951 | 0.00000558 | 1130 |
Missense in Polyphen | 35 | 36.59 | 0.95655 | 407 | ||
Synonymous | -0.380 | 36 | 33.2 | 1.08 | 0.00000156 | 339 |
Loss of Function | 1.21 | 4 | 7.60 | 0.526 | 3.20e-7 | 97 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000444 | 0.0000440 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. {ECO:0000269|PubMed:15814844}.;
- Pathway
- Protein export - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.284
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.12
Haploinsufficiency Scores
- pHI
- 0.196
- hipred
- N
- hipred_score
- 0.309
- ghis
- 0.577
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.173
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Immp2l
- Phenotype
- cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); reproductive system phenotype; pigmentation phenotype; neoplasm; endocrine/exocrine gland phenotype; vision/eye phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- ovarian follicle development;signal peptide processing;protein processing involved in protein targeting to mitochondrion;superoxide metabolic process;cellular response to DNA damage stimulus;spermatogenesis;brain development;blood circulation;respiratory electron transport chain;ovulation;mitochondrial respiratory chain complex assembly;cerebellum vasculature development
- Cellular component
- integral component of membrane;mitochondrial inner membrane peptidase complex
- Molecular function
- peptidase activity;serine-type peptidase activity